Xcout Intel
DewCell
DewCell (Dewcell Biotherapeutics) is a South Korean biotechnology company established in October 2021 and headquartered in Seongnam, South Korea. The company focuses on cutting-edge biotherapeutic research and regenerative medicine.
Subscribe to see DewCell’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
DewCell at a glance
DewCell is a biotechnology company headquartered in South Korea. Its most recent funding round, Series C, raised $16.9M in March 2026. Xcout tracks 4 named people at DewCell, including Lee Min-woo (CEO).
DewCell leadership
- Lee Min-wooCEO
- Minwoo LeeCEO / 대표이사
- Chihwa KimCTO / 전무이사
- Jonghong Hyun이사 경영지원실장/상무이사
DewCell funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $16.9M | 7 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
DewCell competitors
A few of DewCell's closest competitors — see the full list of competitors and alternatives →
GC Cell is a public company headquartered in Yongin-si, Gyeonggi-do, South Korea. The company is at the forefront of cell therapy innovation, with fully-integrated capabilities from research to commercialization.
Kang Stem Biotech Co., Ltd. is a South Korean biotechnology company located in Seoul that specializes in stem cell research and development.
IntoCell is a South Korean biotechnology company founded in 2015 and headquartered in Daejeon, specializing in drug-conjugate and related pharmaceutical technologies.
IMBiologics Corp. is a biotechnology company headquartered in Suwon-si, Gyeonggi-do, South Korea. The firm focuses on drug discovery, development of biotherapeutic pipelines, and clinical trials for innovative antibody treatments.
Medipost Co., Ltd. is a South Korean biotechnology company developing and commercializing stem-cell-based regenerative medicines, including treatments derived from human umbilical cord blood mesenchymal stem cells. It also operates a cord-blood banking business serving expectant parents and families.
LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company headquartered in Daejeon, South Korea. The company is dedicated to the discovery, development, and commercialization of innovative biotechnological solutions.
Get DewCell's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on DewCell in Xcout Intel
- 4 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access